Search
Close
Search
Advanced Search
Search Menu
AI Discovery Assistant

Extract

Introduction

The third edition of Soft Tissue Augmentation, edited by Drs Jean and Alastair Carruthers, is a comprehensive review of presently available soft-tissue injectable fillers and a practical guide for their use. The book contains 31 chapters, grouped into 3 major sections. Chapters 3 through 12 (the first section) address individual agents, including their development, physiochemical properties, and clinical applications. Chapters 13 through 24 pertain to treatment of specific anatomic areas (eg, forehead, glabella, nose) with various agents. The final section, Chapters 26 through 28, deals with possible complications related to fillers (both temporary and permanent) and contains a helpful algorithmic approach to treat these complications.

Strengths

Among the greatest assets of this book are its streamlined approach and exceptional flow. Although the text includes a very comprehensive review of all fillers, it is not overwhelming and is very easy to follow. Each chapter opens with a highlighted “Summary and Key Features” section of salient points within the chapter. Each chapter also features several “Pearls” (highlighted as well) that primarily address the nuanced clinical application of each filler in specific anatomic areas. In Chapters 13 through 24, the anatomic-specific treatment section, many case studies aid in relating hypothetical circumstances to live clinical scenarios. In Chapter 7, Drs Mandy and Fitzgerald discuss how poly-L-lactic acid (PLLA) can restore age-related volume loss in the face, a topic of current interest. They also emphasize the importance of thoroughly understanding each agent’s mode of action, especially that of PLLA. Chapter 9, entitled “New and Novel Fillers,” is another interesting part of the book; several new agents are discussed, as well as products in development. Of special note is the discussion of a new agent composed of non–cross-linked, high-molecular-weight polysaccharides, carboxymethyl cellulose, and polyethylene oxide. Another agent is formulated as a dermal elastin replacement and contains recombinant human tropoelastin protein.

You do not currently have access to this article.
Download all slides